Have a personal or library account? Click to login
The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment Cover

The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment

Journal of Mother and Child
Volume 22 (2018): Issue 1 (March 2018)
By: Magdalena Rychłowska-Pruszyńska,  Joanna Gajewska,  Jadwiga Ambroszkiewicz,  Marek Karwacki and  Katarzyna Szamotulska  
Open Access
|Apr 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.34763/devperiodmed.20182201.5864 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Journal RSS Feed
Language: English
Page range: 58 - 64
Submitted on: Nov 29, 2017
|
Accepted on: Dec 6, 2017
|
Published on: Apr 12, 2018
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
bone tumor,
prognostic marker,
children,
adolescence
Related subjects:
Medicine,
Clinical medicine,
Pediatrics and juvenile medicine,
Paediatric haematology and oncology,
Public health

© 2018 Magdalena Rychłowska-Pruszyńska, Joanna Gajewska, Jadwiga Ambroszkiewicz, Marek Karwacki, Katarzyna Szamotulska, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 22 (2018): Issue 1 (March 2018)Next article